Title: Evaluation of Serum Biomarkers in High Risk Acute Kidney Injury Patients for their Early Detection and Risk Assessment

Authors: Dr Sangita Biswas, Dr Sujit Kumar Dey

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i6.41

Abstract

Background: Acute kidney injury (AKI) is a leading cause of 5-7% of inpatients wards and 30% of all ICU patients with high morbidity and mortality. The need for early detection of renal injury has recently lead to identification of several biomarkers of AKI, that have been found elevated with clinical AKI, in some cases prior to a gold standard diagnostic threshold(rise in serum creatinine by 50%).

Objectives: In search of biomarkers to detect AKI earlier & stratify its risk; cystatin C, Lactate dehydrogenase (LDH), Alkaline phosphatase (ALP), IL-6, IL-18 & Uric acid (UA) were tested from patients’ serum after satisfying all inclusion & exclusion criterias.

Materials & Methods: ELISA (Enzyme Linked Immuno Sorbent Assay) for cystatin C, IL-6, IL-18 and autoanalyzer for LDH, UA, ALP were used to assay them.

Results: 83.72% of stage 1(Acute Kidney Injury Network system) was found among 61.4% of high risk AKI patients. Maximum rise in creatinine occurs early after 24 hrs, which gradually declines in subsequent days. Level of all biomarkers rise in post operative period from 1.2 to 4 times of baselines. Day 1 UA >4.62mg/dl & >17.36% rise from baseline, rise in cystatin C & IL-18 by 94.23% and 23.4% respectively were set as cut-off to predict AKI. Baseline serum creatinine is the strongest predictor of creatinine at 3 &6 months, while baseline cystatin C has found to be moderate strength of prediction from our study.

Keywords: AKI, Cystatin C, LDH, ALP, IL-6, IL-18, UA.

References

  1. Caddeo G, Williams ST, McIntyre CW et al. Acute kidney injury in urology patients: incidence, causes and outcomes. Nephrourol Mon. 2013 Nov;5(5):955-61.
  2. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol. 2003 Aug;14(8):2178-87.
  3. Bjornsson TD. Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet. 1979 May-Jun;4(3):200-22.
  4. Star RA. Treatment of acute renal failure. Kidney Int. 1998 Dec;54(6):1817-31.
  5. Fujisawa N, Yashiro M, Segawa H et al. Discrepancy between cystatin C and creatinine points leading to a diagnosis of post renal acute kidney injury and its reversibility: three case reports. Clin Exp Nephrol. 2010 Dec;14(6):608-13.
  6. Tsuda H, Isaka Y, T akahara S et al. Discrepancy between serum levels of low molecular weight proteins in acute kidney injury model rats with bilateral ureteral obstruction and bilateral nephrectomy. Clin Exp Nephrol. 2009 Dec;13(6):567-70.
  7. Lisowska-Myjak B. serum and urinary biomarkers of acute kidney injury.Blood Purif . 2010;29(4):357-65.
  8. Kim JH, Gil HW, Yang JO et al. Serum uric acid level as a marker for mortality and acute kidney injury in patients with acute paraquat intoxication. Nephrol Dial Transplant. 2011 Jun;26(6):1846-52.
  9. Gaipov A, Solak Y, Turkmen K et al. Serum uric acid may predict development of pregressive acute kidney injury after open heart surgery. Ren Fail. 2015 Feb;37(1):96-102.
  10. Ejaz AA, Dass B, Lingegowda V et al. Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery. Int Urol Nephrol. 2013 Apr;45(2):449-58.
  11. Canet E, Cheminant M, Zafrani L et al. Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumour lysis syndrome? Leuk Lymphoma. 2014 Oct;55(10):2362-7.
  12. Miklaszewska M, Korohoda P, Zachwieja K et al. Serum interleukin 6 levels as an early marker of acute kidney injury on children after cardiac surgery. Adv Clin Exp Med. 2013 May- Jun;22(3):377-86.
  13. Liu KD, Altmann C, Smits G et al. Serum interleukin 6 and interleukin 8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case control study. Crit Care. 2009;13(4):R104.
  14. Che M, Xie B, Xue S et al. Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery. Nephron Clin Pract. 2010;115(1):c66-72.
  15. Zhu L, Shi D. Early diagnostic value of neutrophil gelatinase-associated lipocalin and interleukin 18 in patients with sepsis induced acute kidney injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Aug;28(8):718-22.
  16. Kym D, Cho YS, Yoon J et al. Evaluation of diagnostic biomarkers for acute kidney injury in major burn patients. Ann Surg Treat Res. 2015 May;88(5):281-288.
  17. Pickkers P, Heemskerk S, Schouten J et al. Alkaline phosphatase for treatment of sepsis induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit Care. 2012 Jan 23;16(1):R14.

Corresponding Author

Dr Sujit Kumar Dey

Associate Professor, Dept. of Biochemistry,

4th Floor, Academic Building, R. G. Kar MCH, Kolkata-004, West Bengal, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., M: +91 9433 7257 17